Survey Report
Results of the Bioproducts Production and Development Survey 2015

Highlights

• In 2015, 190 establishments were engaged in the production or development of non-conventional industrial bioproducts in Canada. The majority of these establishments (60.0%) were engaged in bioproduct activities for 10 years or less.
• Bioproduct establishments in 2015 were involved in the production or development of bioproducts, including biofuels, bioenergy, organic chemicals, materials and composites, intermediary biochemicals and biomaterials, and other bioproducts.
• Bioproduct sales were estimated to be $4.3 billion in 2015. Domestic sales accounted for $2.9 billion (66.8%) with exports accounting for $1.4 billion (33.2%). In the international market, annual exports of Canadian bioproducts were primarily to the United States, the European Union, China and Japan.
• Bioproduct co-product sales accounted for $441.5 million in 2015.
• In 2015, 5,618 workers were engaged in bioproduct-related activities (including biomass improvements), with associated salary expenditures of $355 million.
• In 2015, biofuels exceeded other bioproduct categories in terms of both sales and number of establishments. Biofuel sales, totaling $2.7 billion, accounted for 63.6% of all bioproduct sales. Ethanol comprised 75.2% of biofuel sales (over $2 billion) while biodiesel made up 24.1% ($653 million).
• Nearly 60% of all establishments reported involvement (research, development or production) in biofuels. Of these, 30 were involved in ethanol, 29 in biodiesel and 24 in gaseous fuels.
• Biomass purchases totaling $2.3 billion in 2015 served as inputs for bioproduct activities. The two main sources of biomass inputs were forestry biomass, with 12.3 million metric tonnes, and agricultural biomass, with 8.8 million metric tonnes. Grains and oilseeds accounted for 99.0% of the volume of agricultural biomass.
• In-house research-and-development spending on bioproduct development decreased to $91.2 million in 2015, from $101.6 million in 2014.
• In 2015, approximately one-third of bioproduct establishments were involved in collaborative arrangements with other businesses or organizations. These collaborative arrangements, numbering about 218, were predominantly with businesses (both domestic and foreign) and academic institutions in Canada.

Introduction

The bioproducts sector has unexplored potential in Canada. In the last decade, however, efforts have been made to better measure this activity. One of the major reasons for interest in this activity is that the manufacturing of bioproducts offers processors additional markets for new products and commodities. Canada has more biomass resources per capita than any other country and access to a wealth of biomass feedstock.^Note  This paper presents results from the 2015 Bioproducts Production and Development Survey, Statistics Canada’s fourth survey on businesses engaged in this sector. The survey is conducted on a cost-recovery basis by the Centre for Special Business Projects (CSBP) on behalf of Agriculture and Agri-Food Canada (AAFC). Previous iterations of this survey were also conducted for 2003, 2006 and 2009. The objective of the survey is to measure activity in the bioproducts sector.

For the purpose of this survey, bioproducts are defined as “non-conventional” products produced from biomass with the goal of commercialization (see Box 1 definitions below). Thus, all bioproducts produced only for in-house use (e.g., electricity, heat) are ruled out. For example, this definition includes biofuels (e.g., ethanol, biodiesel), bio-gas and bioenergy, organic chemicals (e.g., biopolymers), bio-pesticides, plant-made biologics, non-conventional construction materials and composites, intermediary biochemicals, and biomaterials (if produced in a non-conventional manner), but excludes all food, nutraceuticals, feed (e.g., livestock and pet food), medicines and forestry-based bioproducts produced in a traditional way (e.g., lumber, paper).^Note 

The main objective of this descriptive paper is to give to the reader a better idea of the size and scope of bio-economic activity in the Canadian economy and to provide statistical information on the Canadian bioproducts sector. A detailed profile of establishments engaged in the production and/or development of bioproducts in the country is presented.

Start of text box

End of text box

Survey population

The target population for the survey included all commercial establishments located in Canada that use renewable biomass to develop or produce bioproducts (see definition in Box 1), as well as those that collect, separate and/or refine the biomass inputs used in bioproducts.

The criteria used to define a bioproduct establishment for this survey resulted in a very small population. This is one of the main challenges of the survey. Bioproduct establishments are difficult to identify and find, because bioproducts are not an industry but, rather, activities carried out by establishments. To date, there is no complete database which identifies non-conventional bioproducts and those businesses involved in developing or producing these products. Therefore, a census approach was used to obtain a robust responding population who could self-identify their bioproducts activities, in order to produce reliable estimates. The frame was constructed from three sources:

1. lists of businesses obtained from federal partners, provincial and territorial bioproduct industry associations, and industry experts
2. enterprises from the Business Register System that were in-scope during the Survey of Advanced Technology (2014), the Survey of Innovation and Business Strategy (2012), the Environmental Protection Expenditures Survey (2012), and the previous Bioproducts Production and Development Survey (2009)
3. external sources including association websites.

Only establishments in the following North American Industry Classification System (NAICS) sectors were retained:

• manufacturing (31-33)
• wholesale trade (41)
• professional, scientific and technical services (54)
• agriculture, forestry, fishing and hunting (11)
• mining, quarrying, and oil and gas extraction (21)
• utilities (22).

These sources collectively yielded 1,123 potential in-scope establishments. After an initial contact by phone, the number of potential in-scope establishments was reduced to 599 establishments.^Note  Subsequently, an in-depth analysis was required to remove all remaining out-of-scope establishments. Following the analysis, 190 bioproduct establishments were determined to be in-scope for this survey. Calculated for the final population, the overall survey response rate was established at 48.2%.

This paper presents the findings from the survey on the bioproducts sector in Canada. The annex includes all survey estimates by region (Atlantic provinces, Quebec, Ontario, the Prairies and British Columbia) and by establishment size based on the number of employees (less than 50, 50 to 149, and 150 or more).

Industry profile

In 2015, an estimated 190 Canadian establishments were involved in the production and/or development of non-conventional bioproducts.^{Note  Note}  Chart 1 shows that, geographically, 52.6% were located in central Canada (59 in Ontario and 41 in Quebec). Small establishments (with less than 50 employees) made up the majority of the distribution (71.1%). Medium-sized establishments (with 50 to 149 employees) represented 13.7% of the distribution, and large establishments (with 150 or more employees) accounted for 15.3%.^Note 

Bioproduct establishments were involved in the production and/or development of many types of bioproducts^Note  encompassing a wide range of activities.^Note  These activities involved the production and/or development of biofuels (58.4%),^Note  bioenergy (21.1%), intermediary biochemicals or biomaterials (20.0%), materials and composites (17.4%), organic chemicals (14.2%), and other bioproducts (11.1%). From these estimates, 111 establishments were involved in biofuels, 30 in ethanol, 29 in biodiesel and 24 in gaseous fuels.

Bioproduct establishments profile

Chart 2 shows that, in 2015, there were 61 mature establishments (those in operation for more than 20 years). These accounted for 32.3% of bioproduct establishments. The results show that the majority of establishments (80) were young, having been in operation for 10 years or less. These young establishments made up 42.3% of all bioproduct establishments, while the mid-age groups (11 to 15 years, and 16 to 20 years) made up 25.4%.

Similarly (chart 3), a majority of bioproduct establishments (60%) had indicated that their business had been involved in bioproduct activities for 10 years or less. Less than 10% of the total had been involved in bioproduct activities for 11 to 15 years, 11.1% for 16 to 20 years, and 19.5% for more than 20 years. New businesses tend to engage in bioproduct-related activity from the beginning of operation.

There were various reasons why businesses were engaged in bioproduct activities (table 1). The three main reasons for initially becoming involved in bioproducts were opportunities through education or employment (42.0%), opportunities through business domestic activities (41.0%), and cooperation or collaboration with other establishments or organizations (25.2%).

Business profile

In 2015, sales of bioproducts totaled an estimated $4.3 billion.^Note  Of this total, 66.8% were domestic sales and 33.2% exports. Biofuels represented the most significant bioproduct activity, with sales of $2.7 billion (63.6%)^Note  . Chart 4 shows that, geographically, 44.4% of all bioproduct sales were made by establishments located in Ontario, 27.6% by establishments located in the Prairies, 25.8% by establishments located in Quebec, and less than 2.2% by establishments located in British Columbia. Sales from other business lines (not bioproducts) accounted for 61.0% of establishments’ total sales in 2015.^Note 

In 2015, the majority of bioproduct establishments (83.8%) had clients in Canada. Additionally, 45.6% had clients in the United States, 13.6% had clients in the European Union, 8.6% had clients in China, 7.1% had clients in Japan, and 7.1% had clients in other countries (Chart 5).^Note 

Bioproduct establishments in Canada employed a total of 5,618 people^Note  (where at least 50% of theirs work was devoted to bioproduct and/or biomass activities).^Note  Of this total, 1,879 people were employed by small establishments, 1,661 people were employed by medium-sized establishments, and 2,078 people were employed by large establishments.^Note  In total, these employees earned an estimated $355 million in wages and salaries in 2015.^Note 

Of this workforce, 46.4% had occupations in production and operations, 18.8% in management, marketing or finance, 15.3% in engineering, 9.2% in R&D, and 8.2% in laboratories as laboratory technicians (Chart 6).

In 2015, 17.1% of all bioproduct establishments reported unfilled or vacant positions.^Note  Establishments cited the main reasons for their unfilled employment positions as the inability to find highly qualified personnel (46.9%) and the unwillingness of qualified individuals to relocate (29.0%).^Note 

Contracting or outsourcing services were reported by 34.3% of all bioproduct establishments in 2015.^Note  The most common outsourced activities included engineering services (49.1%), R&D (24.6%), and production of goods (23.0%).^Note  The top two reasons given for contracting out were to “access outside scientific expertise / knowledge” (52.3%) and for “cost-effectiveness” (48.3%).^Note 

Biomass

Forestry biomass was the largest source of biomass produced (table 2), at 12.3 million metric tonnes, of which 8.5 million metric tonnes came from processing residue from pulp-and-paper mills. Agricultural biomass was the second largest source of biomass, with 8.8 million metric tonnes produced, the majority being derived from grains and oilseeds. In 2015, bioproduct establishments incurred biomass costs amounting to $2.3 billion.^Note 

Overall, 42.1% of all establishments used agricultural biomass as their primary source of biomass.^Note  About one-quarter (26.3%) of establishments identified forestry as their primary biomass in 2015. Primary biomass was sourced mainly from the region in which the establishment was located.^Note  In terms of distance travelled to the source of the biomass (graph 7), 14.7% of establishments used on-site biomass; 19.7% obtained the primary biomass from a distance of less than 50 km; and 65.7% had more than 50 km to travel to their primary biomass source.

In 2015, almost one-third of bioproduct establishments in Canada were also using some of their own bioproducts internally (e.g., bioenergy for drying products and heating buildings).^Note  This ratio varies among regions. The Prairies had the lowest proportion of internal bioproduct consumption, with only 14.0% of establishments using their own bioproducts internally, whereas the Atlantic provinces had the highest ratio, at 61.9%.^Note  This ratio can vary, depending on factors such as the type of bioproduct being produced and alternative costs. For example, ethanol might be more profitable to produce for external use, while a cheaper energy source is substituted for internal use.

About one-third (35.3%) of all bioproduct establishments also reported sales of co-products^Note  (e.g., distiller dry grains and CO₂ as co-products of ethanol production).^Note  The Prairies (46.5%) and British Columbia (46.2%) were the leading regions for co-products sales.

In 2015, total sales from co-products amounted to $441.5 million, which represented 10.3% of total bioproduct sales.^Note  Medium-sized establishments accounted for 60.8% of all those sales, while small and large establishments accounted for 31.9% and 7.3% of co-products sales.

Research and development (R&D) and innovation

In 2015, Canadian bioproduct establishments invested $112.1 million in in-house research and development (R&D). ^Note  Of this amount, $91.2 million (81.3%) was spent on bioproduct and biomass activities. Small establishments invested the most in R&D in 2015, accounting for 59.7% of all R&D expenditures. Medium-sized establishments made 31.2% of all R&D expenditures while large establishments accounted for the remaining 9.0% of such expenditures.^Note 

Overall research intensity (measured as expenditures on R&D divided by bioproducts sales) in 2015 was found to be 2.1% when combining bioproduct and biomass activities.^Note 

In addition to in-house R&D investments, establishments can expand their innovative capacity through other avenues. For example, they may cooperate or collaborate with other establishments or institutions to expand (or borrow) expertise, knowledge or technical knowhow. They may also outsource specific research activities or acquire (or lease) intellectual property from other sources to advance their innovative objectives. Establishments may also seek external funding from government programs or use incentives to either finance in-house R&D or access funds to outsource R&D.

In 2014 and 2015, the two main reasons why establishments were attempting to raise capital were to conduct R&D or to expand R&D capacity (about one-third of establishments), and to develop proof of concept or a pilot project (26.8% of establishments).^Note  Furthermore, R&D programs were the most common type of government (federal, provincial and municipal) programs to which bioproduct establishments applied for (about one-third of establishments).^Note  When bioproduct establishments were asked what programs or incentives would be beneficial to their businesses over the next five fiscal years, they identified commercialization programs as the most beneficial followed by R&D programs.^Note 

Over 60% of all bioproduct establishments received Scientific Research and Experimental Development (SR&ED) refunds and/or tax credits over the previous five years, for a total of $100.4 million.^Note  Of those, 65.3% were small establishments. In addition, 58 establishments indicated that they had received Industrial Research Assistance Program (IRAP) funding, of those establishments, 81.0% were small establishments.^Note 

Intellectual property and collaborations

In 2015, 62 establishments had an existing patent or a pending patent, for a total of 1,822 registered patents. Of these patents, 17.0% were registered in Canada, 20.8% in the United States, 17.0% in Europe and 2.0% in Japan. The remaining 43.3% were registered in other counties.^Note  Of the 167 pending patents awaiting approval, 32.3% were filed in Canada, 26.9% in the United States, 22.8% in Europe, 8.4% in Japan and 10.2% elsewhere.

In 2015, 10 bioproduct establishments assigned a bioproduct-related intellectual property licence to a third party and 11 bioproduct establishments acquired at least one intellectual property licence.^Note 

Thirty-seven bioproduct establishments owned at least one bioproduct trademark in 2015.^Note  A total of 102 bioproduct trademarks were registered in 2015, compared to 89 in 2014.

Roughly one-third of establishments (69) participated in collaborative (or cooperative) arrangements with other businesses in 2015.^Note  In total, 218 such arrangements were reported, of which one-quarter were multi-partner arrangements. Small establishments accounted for 66.1% of all bioproduct collaborative arrangements. The most common collaborations were with other businesses. International businesses accounted for 37 of the arrangements, while 48 arrangements were with businesses in Canada^Note  (Chart 8).

Nationally, the most important reasons given in deciding to collaborate with partners, were to access outside scientific expertise/knowledge (80.4%) and to perform R&D (66.5%).^Note  All medium-sized establishments indicated that access to outside scientific expertise/knowledge, access to capital and cost-effectiveness were their main reasons for collaboration.

Challenges

In 2015, the five most cited obstacles (Chart 9) faced by all bioproduct establishments were the difficulty in entering the commercial marketplace, the cost of biomass, the cost and timeliness of regulatory approval, lack of financing and the cost to comply with regulations. However, lack of financing was identified as the “major” challenge faced by many establishments. About 30% of all establishments identified this as a major obstacle, followed by the cost and timeliness of regulatory approval (21.4%), the cost of biomass (16.5%) and the unreliable quantity of biomass (16.4%).^Note 

However, over 50% of establishments indicated that the cost of developing environmental indicators (64.3%), the unreliable quantity of biomass (60.7%), the absence of adequate product standard certification (59.6%), the unreliable quality of biomass (56.2%) and the lack of skilled human resources (53.0%) were not challenges for them.^Note 

Chart 10 shows the number of establishments that applied for federal, provincial and municipal government programs. The two most common programs applied for were bioproduct R&D programs (68 establishments applied) and commercialization programs (47 establishments applied).

Chart 11 shows the types of programs or incentives that would be beneficial for bioproduct establishments. Commercialization programs were identified as being the most beneficial programs for bioproduct establishments over the next five years. This was followed by programs for bioproduct R&D and marketing programs. Considering that entering the commercial marketplace was reported to be the main challenge, it is no surprise that commercialization programs and incentives were identified as being the most helpful to bioproduct establishments.

Conclusion

The 2015 Bioproducts Production and Development Survey focused on bioproduct establishments that produced and developed bioproducts from biomass in a non-conventional way with the aim of selling these bioproducts. This survey reflects results relating to those “specific” bioproducts only and omits a great range of conventional bioproducts.

One hundred ninety (190) bioproduct establishments were found to be in-scope for the survey. Such establishments were diversified and spread across Canada. A large spectrum of bioproduct activities were found, including biofuels, bioenergy, organic chemicals, materials and composites. Intermediary products (i.e., biochemicals and biomaterials) were also reported.

In 2015, bioproduct establishments included a sizable number of young (in operation for 10 years or less) establishments. Moreover, many new entrants into bioproduct production and development were of mature age (in operation for 21+ years). Although the primary source of bioproduct sales in 2015 was biofuels, sales also came from a wide range of bioproduct categories.

Canada’s bioproducts were sold in the domestic market, the United States, Europe and Asia. A greater proportion of sales were in the domestic market; the United States was the main export market.

The research intensity (R&D divided by establishments’ bioproducts sales) of in-house research into bioproducts (including biomass) by bioproduct establishments was 2.1%.

Establishments expanded their research and innovative capacity through external avenues, such as collaborative or cooperative arrangements with other partners, using research incentive programs (e.g., SE&RD and IRAP). In 2015, many establishments had collaborative arrangements. Most of them were with other establishments and with academic institutions, both in Canada and other countries. Those collaborations had the main goal of accessing outside scientific expertise and knowledge, along with undertaking R&D.

The major critical challenge identified in 2015 by bioproduct establishments was lack of financing and the main reason behind seeking additional financing was undertaking R&D and developing proof of concept (or for a pilot project).

Statistics Canada’s 2015 Bioproducts Production and Development Survey attempted to survey all establishments in Canada that used biomass feedstock resources in innovative or novel ways for commercial purposes. The paper’s main objective was to provide an overview of the Canadian bioproducts sector, including the size and scope of activities conducted by bioproduct establishments. The survey was designed to present data on the Canadian bioproducts sector by region and establishment size.

Comparing to previous surveys

A similar survey was also conducted by Statistics Canada for reference years 2003, 2006 and 2009. Given the different survey designs, each iteration needs to be considered separately and not be treated as part of a time-series. The main objective of these surveys is to measure the bioproducts sector in Canada for a specific reference period.

The extent of any attempt to compare survey iterations requires consideration of two aspects:

• changes related to the survey methodologies, including frame, sampling method, edits, imputation and weighting
• changes related to questionnaire content and concept definitions.

As bioproducts in Canada continue to be an evolving and emerging concern, identifying the target population undertaking bioproduct-related activities is challenging. Specific questions relating to the types of bioproducts and biomass used, in order for establishments to self-identify as belonging to the population, reduced the number of in-scope units. The identification of the target population and the list of establishments differed for each iteration of the bioproducts survey. The fact that the survey uses a census approach does not guarantee a census population.

Changes in questionnaire content included modifications to the questionnaire design and modifications to reflect the realities of the market. Furthermore, questions were removed, revised or incorporated according to lessons learned from previous survey iterations and their relevance at the time of the survey.

The development of bioproducts for novel uses of biomass continues to evolve, and such definitions are continually evolving. As these definitions are adjusted, the survey must also adapt to recent bioproduct developments. A strict definition format would make it challenging to keep each survey iteration relevant as well as comparable.

Annex tables

Table A.1 Profile of bioproduct establishments, by region and establishment size, 2015

Table A.2.1 Quantity of biomass used by bioproduct establishments, by biomass type and region, 2015

Table A.2.2 Quantity of biomass used by bioproduct establishments, by biomass type and establishment size, 2015

Table A.3.1 Number of bioproduct establishments involved in bioproduct-related activities, by product type and region, 2015

Table A.3.2 Number of bioproduct establishments involved in bioproduct-related activities, by product type and establishment size, 2015

Table A.4 Number of bioproduct establishments involved in other bioproduct-related activities, by region and establishment size, 2015

Table A.5 Number of bioproduct establishments, by number of years in operation in Canada, region and establishment size, 2015

Table A.6.1 Number of bioproduct establishments originating from an establishment spin-off, by type of organization and region, 2015

Table A.6.2 Number of bioproduct establishments originating from an establishment spin-off, by type of organization and establishment size, 2015

Table A.7.1 Number of bioproduct establishments by type of establishment legal entity and region, 2015

Table A.7.2 Number of bioproduct establishments by type of establishment legal entity and establishment size, 2015

Table A.8.1 Number of bioproduct establishments that are subsidiaries, by location of their ultimate parent and region, 2015

Table A.8.2 Number of bioproduct establishments that are subsidiaries, by location of their ultimate parent and establishment size, 2015

Table A.9 Number of bioproduct establishments located in bio-based clusters, by region and establishment size, 2015

Table A.10.1 Revenue breakdown of bioproduct establishments, by region, 2015

Table A.10.2 Revenue breakdown of bioproduct establishments, by establishment size, 2015

Table A.11.1 Revenues of bioproduct establishments, by product type and region, 2015

Table A.11.2 Revenues of bioproduct establishments, by product type and establishment size, 2015

Table A.12.1 Expense breakdown of bioproduct establishments, by region, 2015

Table A.12.2 Expense breakdown of bioproduct establishments, by establishment size, 2015

Table A.13.1 Wages and salaries paid for main activities by bioproduct establishments, by region, 2015

Table A.13.2 Wages and salaries paid for main activities by bioproduct establishments, by establishment size, 2015

Table A.14 Percentage of bioproduct establishments with in-house research and experimental development (R&D) expenditures in Canada in 2015, by region and establishment size, 2015

Table A.15.1 Total in-house research and development (R&D) expenditures by bioproducts establishments in Canada, by region, 2014 and 2015

Table A.15.2 Total in-house research and development (R&D) expenditures by bioproducts establishments in Canada, by establishment size, 2014 and 2015

Table A.16.1 In-house research and development (R&D) expenditures related to bioproducts in Canada, by region, 2014 and 2015

Table A.16.2 In-house research and development (R&D) expenditures related to bioproducts in Canada, by establishment size, 2014 and 2015

Table A.17 Number of bioproduct establishments, by years engaged in bioproduct-related activities in Canada, region and establishment size, 2015

Table A.18.1 How establishments initially became involved in bioproducts, by region, 2015

Table A.18.2 How establishments initially became involved in bioproducts, by establishment size, 2015

Table A.19 Number of bioproduct establishments producing bioproducts for internal use, by region and establishment size, 2015

Table A.20.1 Number of bioproduct establishments producing co-products for sale, by product type and region, 2015

Table A.20.2 Number of bioproduct establishments producing co-products for sale, by product type and establishment size, 2015

Table A.21 Total sales of co-products by bioproduct establishments, by region and establishment size, 2015

Table A.22 Geographical location of Canadian buyers of bioproducts, by region and establishment size, 2015

Table A.23.1 Factors motivating establishments to develop or produce bioproducts, by region, 2015

Table A.23.2 Factors motivating establishments to develop or produce bioproducts, by establishment size, 2015

Table A.24.1 Obstacles to bioproduct establishments' development or production of bioproducts, by region, 2015

Table A.24.2 Obstacles to bioproduct establishments' development or production of bioproducts, by establishment size, 2015

Table A.25.1 Biomass improvement activities performed by bioproduct establishments, by region, 2015

Table A.25.2 Biomass improvement activities performed by bioproduct establishments, by establishment size, 2015

Table A.26 How bioproduct establishments source biomass, by region and establishment size, 2015

Table A.27.1 Types of biomass suppliers used by bioproduct establishments, by region, 2015

Table A.27.2 Types of biomass suppliers used by bioproduct establishments, by establishment size, 2015

Table A.28.1 Types of biomass reported as primary biomass, by number of establishments, share of total biomass used and region, 2015

Table A.28.2 Types of biomass reported as primary biomass, by number of establishments, share of total biomass used and establishment size, 2015

Table A.29.1 Percentage of primary biomass sourced, by geographical location and region, 2015

Table A.29.2 Percentage of primary biomass sourced, by geographical location and establishment size, 2015

Table A.30 Distance primary biomass was transported, by region and establishment size, 2015

Table A.31.1 Number and types of employees who worked at least 50% of the time in bioproduct activities, by region, 2015

Table A.31.2 Number and types of employees who worked at least 50% of the time in bioproduct activities, by establishment size, 2015

Table A.32 Proportion of bioproduct establishments with unfilled full- or part-time positions related to bioproducts, by region and establishment size, 2015

Table A.33.1 Obstacles to bioproduct establishments filling bioproduct-related job vacancies, by region, 2015

Table A.33.2 Obstacles to bioproduct establishments filling bioproduct-related job vacancies, by establishment size, 2015

Table A.34.1 Locations where bioproduct establishments have considered relocating or opening a new bioproduct facility, by region, 2015

Table A.34.2 Locations where bioproduct establishments have considered relocating or opening a new bioproduct facility , by establishment size, 2015

Table A.35.1 Important factors to bioproduct establishments when considering where to relocate or open a new bioproduct facility, by region, 2015

Table A.35.2 Important factors to bioproduct establishments when considering where to relocate or open a new bioproduct facility, by establishment size, 2015

Table A.36 Proportion of bioproduct establishments that contracted out bioproduct-related activities, by region and establishment size, 2015

Table A.37.1 Number of bioproduct-related activities contracted out by bioproduct establishments, by region, 2015

Table A.37.2 Number of bioproduct-related activities contracted out by bioproduct establishments, by establishment size, 2015

Table A.38.1 Reasons bioproduct establishments contracted out bioproduct-related activities, by level of importance and region, 2015

Table A.38.2 Reasons bioproduct establishments contracted out bioproduct-related activities, by level of importance and establishment size, 2015

Table A.39 Number of bioproduct establishments that participated in bioproduct-related co-operative or collaborative arrangements, by region and establishment size, 2015

Table A.40.1 Number of bioproduct establishments collaborated with during the previous three years, by partnership type and region, 2013-2015

Table A.40.2 Number of bioproduct establishments collaborated with during the previous three years, by partnership type and establishment size, 2013-2015

Table A.41.1 Reasons bioproduct establishments decided to co-operate or collaborate with partners, by level of importance and region, 2015

Table A.41.2 Reasons bioproduct establishments decided to co-operate or collaborate with partners, by level of importance and establishment size, 2015

Table A.42 Number of bioproduct establishments that indicated their customers required sustainably sourced biomass inputs, by region and establishment size, 2015

Table A.43 Number of bioproduct establishments that took steps to verify whether their biomass inputs were sustainably produced, by region and establishment size, 2015

Table A.44 Number and types of methods used by bioproducts establishments to verify whether their biomass inputs were sustainably produced, by region and establishment size, 2015

Table A.45 Number of bioproduct establishments that completed a Life Cycle Analysis (LCA) or an Environmental Product Declaration (EPD®) for their bioproducts, by region and establishment size, 2010-2015

Table A.46.1 Factors preventing bioproduct establishments from completing a Life Cycle Analysis (LCA) or an Environmental Product Declaration (EPD®) for their bioproducts, by region, 2015

Table A.46.2 Factors preventing bioproduct establishments from completing a Life Cycle Analysis (LCA) or an Environmental Product Declaration (EPD®) for their bioproducts, by establishment size, 2015

Table A.47 Number of certified bioproducts, by type of certification, region and establishment size, 2015

Table A.48 Proportion of bioproduct establishments planning to use Life Cycle Analysis (LCA) results to market and/or promote their bioproducts, by region and establishment size, 2015

Table A.49.1 Proportion of bioproduct establishments planning to complete a Life Cycle Analysis (LCA) or an Environmental Product Declaration (EPD®) for any of their bioproducts in fiscal years 2016, 2017 or 2018, by region, 2015

Table A.49.2 Proportion of bioproduct establishments planning to complete a Life Cycle Analysis (LCA) or an Environmental Product Declaration (EPD®) for any of their bioproducts in fiscal years 2016, 2017 or 2018, by establishment size, 2015

Table A.50.1 Number of bioproduct-related patents and pending patents, by geographical area and region, 2015

Table A.50.2 Number of bioproduct-related patents and pending patents, by geographical area and establishment size, 2015

Table A.51.1 Number of unique bioproduct patent applications submitted and number of such applications granted, by year and region, 2014 and 2015

Table A.51.2 Number of unique bioproduct patent applications submitted and number of such applications granted, by year and establishment size, 2014 and 2015

Table A.52.1 Number of bioproduct-related trademarks, by year and region, 2014 and 2015

Table A.52.2 Number of bioproduct-related trademarks, by year and establishment size, 2014 and 2015

Table A.53 Number of bioproduct establishments that assigned or licensed bioproduct-related intellectual property (IP) rights to another establishment or that acquired bioproduct-related IP rights from another establishment, by region and establishment size, 2015

Table A.54.1 Reasons for attempting to raise capital in 2014 and/or 2015, by region, 2014 and 2015

Table A.54.2 Reasons for attempting to raise capital in 2014 and/or 2015, by establishment size, 2014 and 2015

Table A.55.1 Funds requested and received for bioproduct-related activities, by year and region, 2014 and 2015

Table A.55.2 Funds requested and received for bioproduct-related activities, by year and establishment size, 2014 and 2015

Table A.56.1 Total funds raised for bioproduct-related activities, by source and region, 2015

Table A.56.2 Total funds raised for bioproduct-related activities, by source and establishment size, 2015

Table A.57 Number of bioproduct establishments that applied for refunds or tax credits for their bioproduct-related research and development (R&D) expenditures under the Scientific Research and Experimental Development (SR&ED) Tax Incentive Program, in any of the past five fiscal years, by region and establishment size, 2010-2015

Table A.58 Number of bioproduct establishments that received funding from the Industrial Research Assistance Program (IRAP) during the past five years, by region and establishment size, 2010-2015

Table A.59 Number of establishments that applied, in the past five fiscal years, for any other government (federal, provincial or municipal) programs related or applicable to bioproducts, by region and establishment size, 2010-2015

Table A.60.1 Types of government programs (federal, provincial or municipal) for which bioproduct establishments have applied, by region, 2015

Table A.60.2 Types of government programs (federal, provincial or municipal) for which bioproduct establishments have applied, by establishment size, 2015

Table A.61.1 Types of programs or incentives that would be beneficial to the bioproduct-related activities of bioproduct establishments, by region, 2015

Table A.61.2 Types of programs or incentives that would be beneficial to the bioproduct-related activities of bioproduct establishments, by establishment size, 2015

References

The Canadian Trade Commissioner Service website. http://www.international.gc.ca/investors-investisseurs/sector-secteurs/bioproduct-bioproduit.aspx?lang=eng.

Notes